<DOC>
	<DOCNO>NCT00122915</DOCNO>
	<brief_summary>The CONCEPT study design evaluate safety efficacy Motor Cortex Stimulation ( MCS ) new cortical lead ( circular lead , eight electrode , Medtronic Inc , Minneapolis , USA ) treatment intractable neuropathic pain , particular central post-stroke pain ( CPSP ) trigeminal neuropathic pain ( TGN ) /facial pain .</brief_summary>
	<brief_title>CONCEPT : Crossover Efficacy Pain Trial Motor Cortex Stimulation Intractable Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Facial Pain</mesh_term>
	<mesh_term>Pain , Intractable</mesh_term>
	<criteria>CPSP TGN/facial pain refractory medical treatment Pain &gt; 1 year prior baseline Pain intensity average daily VAS score &gt; 5 demonstrate 12 rating across 4 day Stable pain medication &gt; 1 month prior baseline CPSP important paresis/severe motor deficit area pain TGN/facial pain complete deafferentation pain Atypical facial pain , i.e . objective evidence neuropathic facial pain syndrome lack specific psychological behavioral factor identify Pain associate malignant neoplastic disease anywhere body head History epilepsy Presence deterioration cognitive function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Motor Cortex Stimulation</keyword>
	<keyword>Pain treatment</keyword>
	<keyword>Central post-stroke pain ( CPSP )</keyword>
	<keyword>Trigeminal neuropathic pain ( TGN )</keyword>
	<keyword>Facial pain</keyword>
	<keyword>Neurostimuation</keyword>
	<keyword>Cortical lead</keyword>
	<keyword>Neuropathic pain</keyword>
</DOC>